List of Tables
Table 1. Global Oxcarbazepine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Oxcarbazepine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Oxcarbazepine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oxcarbazepine Sales (M Unit) of Key Manufacturers (2020-2025)
Table 5. Global Oxcarbazepine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Oxcarbazepine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Oxcarbazepine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Oxcarbazepine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Oxcarbazepine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oxcarbazepine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oxcarbazepine, Product Type & Application
Table 12. Global Key Manufacturers of Oxcarbazepine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oxcarbazepine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxcarbazepine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oxcarbazepine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Oxcarbazepine Sales by Region (2020-2025) & (M Unit)
Table 18. Global Oxcarbazepine Sales Market Share by Region (2020-2025)
Table 19. Global Oxcarbazepine Sales by Region (2026-2031) & (M Unit)
Table 20. Global Oxcarbazepine Sales Market Share by Region (2026-2031)
Table 21. Global Oxcarbazepine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Oxcarbazepine Revenue Market Share by Region (2020-2025)
Table 23. Global Oxcarbazepine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Oxcarbazepine Revenue Market Share by Region (2026-2031)
Table 25. North America Oxcarbazepine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Oxcarbazepine Sales by Country (2020-2025) & (M Unit)
Table 27. North America Oxcarbazepine Sales by Country (2026-2031) & (M Unit)
Table 28. North America Oxcarbazepine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Oxcarbazepine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Oxcarbazepine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Oxcarbazepine Sales by Country (2020-2025) & (M Unit)
Table 32. Europe Oxcarbazepine Sales by Country (2026-2031) & (M Unit)
Table 33. Europe Oxcarbazepine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Oxcarbazepine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Oxcarbazepine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Oxcarbazepine Sales by Region (2020-2025) & (M Unit)
Table 37. Asia Pacific Oxcarbazepine Sales by Region (2026-2031) & (M Unit)
Table 38. Asia Pacific Oxcarbazepine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Oxcarbazepine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oxcarbazepine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Oxcarbazepine Sales by Country (2020-2025) & (M Unit)
Table 42. Latin America Oxcarbazepine Sales by Country (2026-2031) & (M Unit)
Table 43. Latin America Oxcarbazepine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oxcarbazepine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Oxcarbazepine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Oxcarbazepine Sales by Country (2020-2025) & (M Unit)
Table 47. Middle East and Africa Oxcarbazepine Sales by Country (2026-2031) & (M Unit)
Table 48. Middle East and Africa Oxcarbazepine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Oxcarbazepine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Oxcarbazepine Sales (M Unit) by Type (2020-2025)
Table 51. Global Oxcarbazepine Sales (M Unit) by Type (2026-2031)
Table 52. Global Oxcarbazepine Sales Market Share by Type (2020-2025)
Table 53. Global Oxcarbazepine Sales Market Share by Type (2026-2031)
Table 54. Global Oxcarbazepine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Oxcarbazepine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Oxcarbazepine Revenue Market Share by Type (2020-2025)
Table 57. Global Oxcarbazepine Revenue Market Share by Type (2026-2031)
Table 58. Global Oxcarbazepine Price (USD/Unit) by Type (2020-2025)
Table 59. Global Oxcarbazepine Price (USD/Unit) by Type (2026-2031)
Table 60. Global Oxcarbazepine Sales (M Unit) by Application (2020-2025)
Table 61. Global Oxcarbazepine Sales (M Unit) by Application (2026-2031)
Table 62. Global Oxcarbazepine Sales Market Share by Application (2020-2025)
Table 63. Global Oxcarbazepine Sales Market Share by Application (2026-2031)
Table 64. Global Oxcarbazepine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Oxcarbazepine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Oxcarbazepine Revenue Market Share by Application (2020-2025)
Table 67. Global Oxcarbazepine Revenue Market Share by Application (2026-2031)
Table 68. Global Oxcarbazepine Price (USD/Unit) by Application (2020-2025)
Table 69. Global Oxcarbazepine Price (USD/Unit) by Application (2026-2031)
Table 70. Novartis (Trileptal) Company Information
Table 71. Novartis (Trileptal) Description and Business Overview
Table 72. Novartis (Trileptal) Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Novartis (Trileptal) Oxcarbazepine Product
Table 74. Novartis (Trileptal) Recent Developments/Updates
Table 75. Supernus Pharmaceuticals (Oxtellar XR) Company Information
Table 76. Supernus Pharmaceuticals (Oxtellar XR) Description and Business Overview
Table 77. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product
Table 79. Supernus Pharmaceuticals (Oxtellar XR) Recent Developments/Updates
Table 80. Sun Pharm Company Information
Table 81. Sun Pharm Description and Business Overview
Table 82. Sun Pharm Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Sun Pharm Oxcarbazepine Product
Table 84. Sun Pharm Recent Developments/Updates
Table 85. Ranbaxy Pharmaceuticals Company Information
Table 86. Ranbaxy Pharmaceuticals Description and Business Overview
Table 87. Ranbaxy Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Ranbaxy Pharmaceuticals Oxcarbazepine Product
Table 89. Ranbaxy Pharmaceuticals Recent Developments/Updates
Table 90. Jubilant Generics Company Information
Table 91. Jubilant Generics Description and Business Overview
Table 92. Jubilant Generics Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Jubilant Generics Oxcarbazepine Product
Table 94. Jubilant Generics Recent Developments/Updates
Table 95. Taro Pharmaceuticals Company Information
Table 96. Taro Pharmaceuticals Description and Business Overview
Table 97. Taro Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Taro Pharmaceuticals Oxcarbazepine Product
Table 99. Taro Pharmaceuticals Recent Developments/Updates
Table 100. Mylan Company Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Mylan Oxcarbazepine Product
Table 104. Mylan Recent Developments/Updates
Table 105. Stada Group Company Information
Table 106. Stada Group Description and Business Overview
Table 107. Stada Group Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Stada Group Oxcarbazepine Product
Table 109. Stada Group Recent Developments/Updates
Table 110. Glenmark Pharmaceuticals Company Information
Table 111. Glenmark Pharmaceuticals Description and Business Overview
Table 112. Glenmark Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Glenmark Pharmaceuticals Oxcarbazepine Product
Table 114. Glenmark Pharmaceuticals Recent Developments/Updates
Table 115. ANI Pharmaceuticals Company Information
Table 116. ANI Pharmaceuticals Description and Business Overview
Table 117. ANI Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. ANI Pharmaceuticals Oxcarbazepine Product
Table 119. ANI Pharmaceuticals Recent Developments/Updates
Table 120. Teva Pharmaceutical Company Information
Table 121. Teva Pharmaceutical Description and Business Overview
Table 122. Teva Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Teva Pharmaceutical Oxcarbazepine Product
Table 124. Teva Pharmaceutical Recent Developments/Updates
Table 125. Roxane Laboratories Company Information
Table 126. Roxane Laboratories Description and Business Overview
Table 127. Roxane Laboratories Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Roxane Laboratories Oxcarbazepine Product
Table 129. Roxane Laboratories Recent Developments/Updates
Table 130. Nobelpharma Company Information
Table 131. Nobelpharma Description and Business Overview
Table 132. Nobelpharma Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Nobelpharma Oxcarbazepine Product
Table 134. Nobelpharma Recent Developments/Updates
Table 135. Apotex Company Information
Table 136. Apotex Description and Business Overview
Table 137. Apotex Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Apotex Oxcarbazepine Product
Table 139. Apotex Recent Developments/Updates
Table 140. Nexgen pharma Company Information
Table 141. Nexgen pharma Description and Business Overview
Table 142. Nexgen pharma Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Nexgen pharma Oxcarbazepine Product
Table 144. Nexgen pharma Recent Developments/Updates
Table 145. Amneal Pharmaceuticals Company Information
Table 146. Amneal Pharmaceuticals Description and Business Overview
Table 147. Amneal Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Amneal Pharmaceuticals Oxcarbazepine Product
Table 149. Amneal Pharmaceuticals Recent Developments/Updates
Table 150. Hikma Pharmaceuticals Company Information
Table 151. Hikma Pharmaceuticals Description and Business Overview
Table 152. Hikma Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Hikma Pharmaceuticals Oxcarbazepine Product
Table 154. Hikma Pharmaceuticals Recent Developments/Updates
Table 155. Jamp Pharma Company Information
Table 156. Jamp Pharma Description and Business Overview
Table 157. Jamp Pharma Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Jamp Pharma Oxcarbazepine Product
Table 159. Jamp Pharma Recent Developments/Updates
Table 160. Neuraxpharm Company Information
Table 161. Neuraxpharm Description and Business Overview
Table 162. Neuraxpharm Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Neuraxpharm Oxcarbazepine Product
Table 164. Neuraxpharm Recent Developments/Updates
Table 165. Orion Corporation Company Information
Table 166. Orion Corporation Description and Business Overview
Table 167. Orion Corporation Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Orion Corporation Oxcarbazepine Product
Table 169. Orion Corporation Recent Developments/Updates
Table 170. Sihuan Pharm Company Information
Table 171. Sihuan Pharm Description and Business Overview
Table 172. Sihuan Pharm Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Sihuan Pharm Oxcarbazepine Product
Table 174. Sihuan Pharm Recent Developments/Updates
Table 175. Humanwell Healthcare Company Information
Table 176. Humanwell Healthcare Description and Business Overview
Table 177. Humanwell Healthcare Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Humanwell Healthcare Oxcarbazepine Product
Table 179. Humanwell Healthcare Recent Developments/Updates
Table 180. Huikang Pharmaceutical Company Information
Table 181. Huikang Pharmaceutical Description and Business Overview
Table 182. Huikang Pharmaceutical Oxcarbazepine Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. Huikang Pharmaceutical Oxcarbazepine Product
Table 184. Huikang Pharmaceutical Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Oxcarbazepine Distributors List
Table 188. Oxcarbazepine Customers List
Table 189. Oxcarbazepine Market Trends
Table 190. Oxcarbazepine Market Drivers
Table 191. Oxcarbazepine Market Challenges
Table 192. Oxcarbazepine Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
Table 196. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oxcarbazepine
Figure 2. Global Oxcarbazepine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oxcarbazepine Market Share by Type: 2024 & 2031
Figure 4. Tablets (150mg, 300mg, 600mg) Product Picture
Figure 5. Oral Suspension Product Picture
Figure 6. Global Oxcarbazepine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Oxcarbazepine Market Share by Application: 2024 & 2031
Figure 8. Pediatric Use (Aged 2-4 years, 4-16 years)
Figure 9. Adult Use
Figure 10. Global Oxcarbazepine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Oxcarbazepine Market Size (2020-2031) & (US$ Million)
Figure 12. Global Oxcarbazepine Sales (2020-2031) & (M Unit)
Figure 13. Global Oxcarbazepine Average Price (USD/Unit) & (2020-2031)
Figure 14. Oxcarbazepine Report Years Considered
Figure 15. Oxcarbazepine Sales Share by Manufacturers in 2024
Figure 16. Global Oxcarbazepine Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Oxcarbazepine Players: Market Share by Revenue in Oxcarbazepine in 2024
Figure 18. Oxcarbazepine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Oxcarbazepine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Oxcarbazepine Sales Market Share by Country (2020-2031)
Figure 21. North America Oxcarbazepine Revenue Market Share by Country (2020-2031)
Figure 22. United States Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Oxcarbazepine Sales Market Share by Country (2020-2031)
Figure 25. Europe Oxcarbazepine Revenue Market Share by Country (2020-2031)
Figure 26. Germany Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Oxcarbazepine Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Oxcarbazepine Revenue Market Share by Region (2020-2031)
Figure 33. China Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Oxcarbazepine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Oxcarbazepine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Oxcarbazepine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Oxcarbazepine Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Oxcarbazepine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Oxcarbazepine by Type (2020-2031)
Figure 53. Global Revenue Market Share of Oxcarbazepine by Type (2020-2031)
Figure 54. Global Oxcarbazepine Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Oxcarbazepine by Application (2020-2031)
Figure 56. Global Revenue Market Share of Oxcarbazepine by Application (2020-2031)
Figure 57. Global Oxcarbazepine Price (USD/Unit) by Application (2020-2031)
Figure 58. Oxcarbazepine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
